Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non–Small-Cell Lung CancerCaroline E. McCoach, Karen Kelly, David R. Gandara et al.|JCO Precision Oncology|2021Cited by 35